title: Lipid Management in Human Immunodeficiency Virus.
abstract: The development and use of antiretroviral medications to treat patients infected with human immunodeficiency virus (HIV) has dramatically changed the course of this disease from one that was fatal to a chronic and more manageable condition. Recommendations and guidelines for the general population are presented in this review with suggestions as to how they may be applied to this patient population. Issues for which there is little or no information available are noted to highlight the many gaps in our knowledge regarding diagnosis and management of dyslipidemia for patients living with HIV.
authors.affiliation: Cardiovascular Disease Prevention Program & Lipid Clinic, Cardiology Section, Institute for Advanced Medicine (HIV), Mount Sinai St. Luke's, Mount Sinai Roosevelt, 1111 Amsterdam Avenue, New York, NY 10025, USA. Electronic address: myersonm@optonline.net.
authors.forename: Merle
authors.initials: M
authors.lastname: Myerson
keywords: Antiretroviral therapy; Cardiovascular risk factors; Dyslipidemia; HIV; Infectious diseases